IMUX Immunic Therapeutics Year-over-year net earnings per share growth for the last 12 months
Immunic, Inc. (IMUX) is developing oral therapies for colitis and multiple sclerosis, aiming to redefine standards of care. The quarterly EPS trajectory illustrates the efficiency of converting demand into revenue, while 60.40 captures the magnitude of this parameter. The company is expanding its drug portfolio to penetrate the immunotherapy segment, leveraging patent protection and strict FDA regulations.
Summary analytical data breakdowns for Immunic, Inc. (IMUX)
- market value and analyst target forecast:
- market capitalization data:
- book capitalization indicators:
- debt and liquidity data:
Total Debt to Capital Immunic, Inc.|IMUX - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity immunic-therapeutics.com|IMUX - Company Total Debt|Debt to Book Capitalization Ratio Immunic Inc|IMUX - Company Long-Term Liabilities|Company Current Liabilities Immunic|Quick Liquidity immunic-therapeutics.com
- earnings and market multiples details:
IMUX - Company Profit|Projected Future Earnings Immunic, Inc.|IMUX - Business Payback Period|Forward P/E Multiple immunic-therapeutics.com|IMUX - Price/Earnings to Growth Multiple|Enterprise Value to EBITDA Ratio Immunic Inc|IMUX - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Immunic|IMUX - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months immunic-therapeutics.com|IMUX - Earnings per share growth this year|Earnings growth forecast for next year Immunic, Inc.
Basic company analysis:Immunic, Inc.
For Immunic, Inc. (IMUX), the quarterly earnings per share trend serves as an indicator of drug development efficiency amid geopolitical risks and patent restrictions. This metric measures the percentage change in net income per share relative to the previous period, allowing investors to distinguish real capitalization growth from speculative revaluations of biotech sector assets.
Main competitors
argenx (ARGX) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months BioNTech Inc.|Year-over-year net earnings per share growth for the last 12 months ABVX|Quarterly EPS earnings growth ADMA Corp|Year-over-year earnings per share growth for the last twelve months Protagonist Therapeutics (PTGX)|immunovant.com - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth KNSA (Kiniksa)|Grifols SA (GRFS) - Earnings per share growth in annualized terms for the last twelve months|Adaptive Biotechnologies Corp - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months Celldex Corp CLDX|Aurinia Pharmaceuticals (AUPH) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months biocryst.com|Year-over-year earnings per share growth for the last twelve months Vera Therapeutics|Year-over-year net earnings per share growth for the last 12 months Dianthus Therapeutics Inc (DNTH)|Year-over-year net earnings per share growth for the last 12 months PHVS (Pharvaris Corp)|Quarterly EPS earnings growth AbCellera Bio (ABCL)|Year-over-year earnings per share growth for the last twelve months Tourmaline Bio, Inc. TRML|PGEN: Year-over-year earnings per share growth for the last 12 months|Pharming Group - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months Nektar Therapeutics Inc NKTR|UPB: Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Zenas Corp|Year-over-year net earnings per share growth for the last 12 months IMNM|GOSS: Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth KALV|Year-over-year net earnings per share change for the last twelve months Septerna, Inc.|Year-over-year earnings per share growth for the last twelve months Pieris Pharmaceuticals Inc PVLA|SVRA: Year-over-year earnings per share growth for the last 12 months|Rigel Pharmaceuticals - Quarterly EPS earnings growth|anaptysbio.com (ANAB) - Year-over-year net earnings per share growth for the last 12 months|ATXS (Astria Therapeutics, Inc.) - Year-over-year net earnings per share growth for the last 12 months|ENGN - Year-over-year net earnings per share change for the last twelve months|RAPT (RAPT Therapeutics) - Quarterly EPS earnings growth|Aerovate (JBIO) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Aclaris Therapeutics (ACRS)|Year-over-year net earnings per share growth for the last 12 months kyvernatx.com KYTX|Tiziana Life Sciences Ltd - Year-over-year net earnings per share growth for the last 12 months|Quarterly EPS earnings growth Cabaletta Bio Inc. CABA|VTYX: Year-over-year net earnings per share growth for the last 12 months|THTX (Theratechnologies, Inc) - Year-over-year earnings per share growth for the last 12 months|Avalo Therapeutics, Inc (AVTX) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share trend for the last twelve months ELDN (eledon.com)|AGEN (Agenus Inc.) - Quarterly EPS earnings growth|CLYM: Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth ZURA|Quarterly EPS earnings growth aTyr Pharmaceuticals (ATYR)|Year-over-year earnings per share growth for the last twelve months Adagene Inc. ADAG|Year-over-year earnings per one share growth for the last 12 months IMA|STTK - Year-over-year earnings per share growth for the last twelve months|Equillium, Inc. (EQ) - Year-over-year net earnings per share growth for the last 12 months|CNTB: Quarterly EPS earnings growth|Atara Bio (ATRA) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months IFRX|XFOR: Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth ACET|Year-over-year net earnings per share change for the last twelve months celularity.com|Year-over-year earnings per share growth for the last twelve months INmune Bio Corp INMB|BRNS - Year-over-year net earnings per share growth for the last 12 months|KZR - Year-over-year earnings per share growth for the last twelve months|sabbiotherapeutics.com (SABS) - Year-over-year net earnings per share growth for the last 12 months|AKTX (Akari Therapeutics Plc) - Year-over-year net earnings per share growth for the last 12 months|Enlivex Therapeutics Ltd. (ENLV) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months Q32 Bio Inc|Year-over-year earnings per share growth for the last 12 months GOVX (GeoVax Corp)|Quarterly EPS earnings growth EDSA|IBIO - Earnings per share growth in annualized terms for the last twelve months|Quarterly EPS earnings growth CARM (Carisma Therapeutics Inc.)|Year-over-year net earnings per share change for the last twelve months XTL Biopharmaceuticals Ltd (XTLB)|BOLT - Year-over-year earnings per share growth for the last twelve months|HCW Biologics Inc. (HCWB) - Year-over-year net earnings per share growth for the last 12 months|aptevotherapeutics.com (APVO) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months aimimmuno.com|Year-over-year net earnings per share growth for the last 12 months ADTX|Quarterly EPS earnings growth GRI Bio Inc|Year-over-year earnings per share growth for the last twelve months XORTX (XRTX)|Vyome Therapeutics - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth REVB (Revelation Biosciences)|Year-over-year net earnings per share change for the last twelve months indaptusrx.com (INDP)|Scinai Immunotherapeutics Ltd. - Quarterly EPS earnings growth|CalciMedica, Inc. (CALI) - Year-over-year net earnings per share growth for the last 12 months|AFMD (affimed.com) - Year-over-year net earnings per share growth for the last 12 months|Allakos - Year-over-year earnings per one share growth for the last 12 months|HOOK (HOOKIPA Pharma, Inc.) - Quarterly EPS earnings growth|IGM Bio (IGMS) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months iTeos Therapeutics, Inc. (ITOS)|Ocean Biomedical Inc - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth TCBP (TC BioPharm (Holdings) PLC)|THRD - Year-over-year net earnings per share growth for the last 12 months
